Elizabeth Holmes, founder of the now-defunct Theranos, has begun her 11-year sentence for defrauding investors of millions of dollars. Holmes was able to raise more than $700 million in venture capital funding for the company, but its technology was never able to live up to its promise and was eventually exposed as a fraud. Her conviction serves as a reminder of the consequences of fraud and the importance of due diligence when investing.